Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-015802
Filing Date
2022-04-27
Accepted
2022-04-27 20:36:18
Documents
1
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4677
  Complete submission text file 0000899243-22-015802.txt   6280
Mailing Address 25 DAVIDS DR HAUPPAUGE NY 11788
Business Address 25 DAVIDS DR HAUPPAUGE NY 11788 631-273-2828
UNITED BIOMEDICAL INC (Reporting) CIK: 0000896839 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41058 | Film No.: 22861744
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations